The upcoming meeting, taking place on November 10 at Mila, will explore how we can collectively develop, govern, and deploy high-performing, reliable, and secure agentic systems by connecting academic researchers, industry experts, and practitioners.
Join us on the Venture Scientist Bootcamp, a full time, 4-month incubator at Mila, built specifically for deep tech founders with elite STEM backgrounds. You have until November 21, 2026 to apply!
We use cookies to analyze the browsing and usage of our website and to personalize your experience. You can disable these technologies at any time, but this may limit certain functionalities of the site. Read our Privacy Policy for more information.
Setting cookies
You can enable and disable the types of cookies you wish to accept. However certain choices you make could affect the services offered on our sites (e.g. suggestions, personalised ads, etc.).
Essential cookies
These cookies are necessary for the operation of the site and cannot be deactivated. (Still active)
Analytics cookies
Do you accept the use of cookies to measure the audience of our sites?
Multimedia Player
Do you accept the use of cookies to display and allow you to watch the video content hosted by our partners (YouTube, etc.)?
Prognostic data extraction harnessing a privacy-preserving large language model: a clinician-AI collaborative retrospective evaluation in head and neck oncology
Privacy regulations and limited expert-validation constrain the deployment of large language models (LLMs) for electronic health record stru… (see more)cturing. We evaluated locally deployed LLMs to extract 30 prognostic variables from 1,360 head and neck cancer reports (882 patients) using zero-shot prompting. A stratified 50-case subset was reviewed by three radiation oncologists (50 cases, 30 fields, 3 reviewers; 4,500 decisions) to form a majority-vote reference for Llama3.3-70B, which achieved 98.6% F1 with high clinician agreement and processed reports in 53 s/report. Among seven additional models (2.6B-70B) benchmarked against this reference, GPT-OSS-20.9B (F1 89.4%) and MedGemma-27B (F1 88.5%) performed best. Integrating LLM-extracted HPV status, smoking history, and Charlson Comorbidity Score into a multivariate Cox Proportional Hazards model (age, sex, T/N stage) improved disease-free survival (likelihood ratio test p = 0.014; ΔC-index + 0.071) and locoregional failure-free survival (p = 0.026; ΔC-index + 0.108) with 1,000-bootstrap internal validation. This clinician-AI collaborative evaluation shows that on-premises LLMs enable privacy-preserving and efficient tumour board support, longitudinal data curation, and outcome prediction.
Background and Purpose: Radiotherapy targets DNA in cancer cell nuclei. Radiation dose, however, is prescribed to a macroscopic target volum… (see more)e assuming uniform distribution, failing to consider microscopic variations in dose absorbed by individual nuclei. This study investigated a potential link between pre-treatment tumour nuclear size distributions and post-radiotherapy outcomes in gynecological squamous cell carcinoma (SCC). Materials and Methods: Our multi-institutional cohort consisted of 191 non-metastatic gynecological SCC patients who had received radiotherapy with diagnostic whole slide images (WSIs) available. Tumour nuclear size distribution mean and standard deviation were extracted from WSIs using deep learning, and used to predict progression-free interval (PFI) and overall survival (OS) in multivariate Cox proportional hazards (CoxPH) analysis adjusted for age and clinical stage. Results: Multivariate CoxPH analysis revealed that a larger nuclear size distribution mean results in more favorable outcomes for PFI (HR = 0.45, 95% CI: 0.19 - 1.09, p = 0.084) and OS (HR = 0.55, 95% CI: 0.24 - 1.25, p = 0.16), and that a larger nuclear size standard deviation results in less favorable outcomes for PFI (HR = 7.52, 95% CI: 1.43 - 39.52, p = 0.023) and OS (HR = 4.67, 95% CI: 0.96 - 22.57, p = 0.063). The bootstrap-validated C-statistic was 0.56 for PFI and 0.57 for OS. Conclusion: Despite low accuracy, tumour nuclear size heterogeneity aided prognostication over standard clinical variables and was associated with outcomes following radiotherapy in gynecological SCC. This highlights the potential importance of personalized multiscale dosimetry and warrants further large-scale pan-cancer studies.
2025-06-18
Physics and Imaging in Radiation Oncology (published)
256 Patient-Specific Pre-Treatment Nuclei Size Distribution is of Significance for Post Radiation Therapy Locoregional Recurrence and Survival Outcomes